Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1347954rdf:typepubmed:Citationlld:pubmed
pubmed-article:1347954lifeskim:mentionsumls-concept:C0026339lld:lifeskim
pubmed-article:1347954lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:1347954lifeskim:mentionsumls-concept:C0205095lld:lifeskim
pubmed-article:1347954lifeskim:mentionsumls-concept:C1533685lld:lifeskim
pubmed-article:1347954lifeskim:mentionsumls-concept:C0504074lld:lifeskim
pubmed-article:1347954lifeskim:mentionsumls-concept:C0003467lld:lifeskim
pubmed-article:1347954lifeskim:mentionsumls-concept:C0243192lld:lifeskim
pubmed-article:1347954lifeskim:mentionsumls-concept:C0379900lld:lifeskim
pubmed-article:1347954lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:1347954pubmed:issue2lld:pubmed
pubmed-article:1347954pubmed:dateCreated1992-4-22lld:pubmed
pubmed-article:1347954pubmed:abstractTextThe purpose of the present study was two-fold. Firstly, to present a more comprehensive analysis of the disinhibitory effects of 5-HT1A receptor agonists after discrete dorsal raphe (DRN) injections (Higgins et al. 1988). Secondly, the effects of the 5-HT1B receptor agonist CGS12066B and the 5-HT1B/1C agonist mCPP were examined following injection into this nucleus. The increases in social interaction (SI) induced by intra-raphe injections of 8-OH DPAT (0.02-1 micrograms), buspirone (0.04-0.2 microgram), ipsapirone (0.2 microgram) and gepirone (0.2-1 micrograms) under a high light unfamiliar paradigm (HLU) were typically due to increased bout frequency, duration and a higher incidence of sniff, follow, allogroom behaviour. These increases were qualitatively similar to those seen in control animals tested under low light/familiar (LLF) conditions, thus supporting the belief that the drug-induced increases in SI reflected decreases in anxiety. Furthermore, at doses effective under the HLU condition, 8-OH DPAT, buspirone and gepirone failed to modify SI under conditions of minimal suppression (LLF paradigm). At doses which significantly increased punished responding in a water-lick conflict test 8-OH DPAT, ipsapirone and gepirone tended to also increase unpunished rates of drinking. However, in drug untreated rats, prior habituation to the test apparatus also increased unpunished drinking, suggesting some neophobia-induced suppression. At a comparatively high dose, the 5-HT1B agonist CGS12066B (2.5 micrograms), but not the putative 5-HT1B/1C agonist mCPP (0.5-12.5 micrograms), increased SI under the HLU condition.(ABSTRACT TRUNCATED AT 250 WORDS)lld:pubmed
pubmed-article:1347954pubmed:languageenglld:pubmed
pubmed-article:1347954pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347954pubmed:citationSubsetIMlld:pubmed
pubmed-article:1347954pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347954pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347954pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347954pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347954pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347954pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347954pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347954pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347954pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347954pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347954pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1347954pubmed:statusMEDLINElld:pubmed
pubmed-article:1347954pubmed:issn0033-3158lld:pubmed
pubmed-article:1347954pubmed:authorpubmed-author:OakleyN RNRlld:pubmed
pubmed-article:1347954pubmed:authorpubmed-author:HigginsG AGAlld:pubmed
pubmed-article:1347954pubmed:authorpubmed-author:KRAFTR ARAlld:pubmed
pubmed-article:1347954pubmed:issnTypePrintlld:pubmed
pubmed-article:1347954pubmed:volume106lld:pubmed
pubmed-article:1347954pubmed:ownerNLMlld:pubmed
pubmed-article:1347954pubmed:authorsCompleteYlld:pubmed
pubmed-article:1347954pubmed:pagination261-7lld:pubmed
pubmed-article:1347954pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:1347954pubmed:meshHeadingpubmed-meshheading:1347954-...lld:pubmed
pubmed-article:1347954pubmed:meshHeadingpubmed-meshheading:1347954-...lld:pubmed
pubmed-article:1347954pubmed:meshHeadingpubmed-meshheading:1347954-...lld:pubmed
pubmed-article:1347954pubmed:meshHeadingpubmed-meshheading:1347954-...lld:pubmed
pubmed-article:1347954pubmed:meshHeadingpubmed-meshheading:1347954-...lld:pubmed
pubmed-article:1347954pubmed:meshHeadingpubmed-meshheading:1347954-...lld:pubmed
pubmed-article:1347954pubmed:meshHeadingpubmed-meshheading:1347954-...lld:pubmed
pubmed-article:1347954pubmed:meshHeadingpubmed-meshheading:1347954-...lld:pubmed
pubmed-article:1347954pubmed:meshHeadingpubmed-meshheading:1347954-...lld:pubmed
pubmed-article:1347954pubmed:meshHeadingpubmed-meshheading:1347954-...lld:pubmed
pubmed-article:1347954pubmed:meshHeadingpubmed-meshheading:1347954-...lld:pubmed
pubmed-article:1347954pubmed:meshHeadingpubmed-meshheading:1347954-...lld:pubmed
pubmed-article:1347954pubmed:meshHeadingpubmed-meshheading:1347954-...lld:pubmed
pubmed-article:1347954pubmed:meshHeadingpubmed-meshheading:1347954-...lld:pubmed
pubmed-article:1347954pubmed:meshHeadingpubmed-meshheading:1347954-...lld:pubmed
pubmed-article:1347954pubmed:meshHeadingpubmed-meshheading:1347954-...lld:pubmed
pubmed-article:1347954pubmed:meshHeadingpubmed-meshheading:1347954-...lld:pubmed
pubmed-article:1347954pubmed:year1992lld:pubmed
pubmed-article:1347954pubmed:articleTitleEffect of 5-HT1A receptor agonists in two models of anxiety after dorsal raphe injection.lld:pubmed
pubmed-article:1347954pubmed:affiliationDepartment of Neuropharmacology, Glaxo Group Research Ltd., Ware, Herts, UK.lld:pubmed
pubmed-article:1347954pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1347954lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1347954lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1347954lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1347954lld:pubmed